Corbus Pharmaceuticals Holdings (CRBP) Return on Capital Employed Growth (5y) (2019 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) Return on Capital Employed Growth (5y) (2019 - 2025) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.67 Bn | 466.88 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.32 Bn | 115.07 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.55 Bn | 34.54 Bn | 959.66 Mn |
| 10 | Corbus Pharmaceuticals Holdings | 112.37 Mn | 84.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 21,286.00 |
| Jun 30, 2025 | 29,507.00 |
| Mar 31, 2025 | 34,041.00 |
| Dec 31, 2024 | 30,869.00 |
| Sep 30, 2024 | 12,383.00 |
| Jun 30, 2024 | 6,478.00 |
| Mar 31, 2024 | 26,999.00 |
| Dec 31, 2023 | -1.16 Mn |
| Sep 30, 2023 | -43,847.00 |
| Jun 30, 2023 | -7,224.00 |
| Mar 31, 2023 | -4,911.00 |
| Dec 31, 2022 | 382.00 |
| Sep 30, 2022 | 1,235.00 |
| Jun 30, 2022 | -140.00 |
| Mar 31, 2022 | 1,609.00 |
| Sep 30, 2021 | 3,611.00 |
| Jun 30, 2021 | 2,416.00 |
| Mar 31, 2021 | 2,314.00 |
| Dec 31, 2020 | -8,939.00 |
| Sep 30, 2020 | -15,294.00 |